» Share this page

Friday December 7, 2012

Génome Québec wishes to acknowledge the scientific contribution of Dr. Daniel Gaudet, Scientific Director of the Génome Québec and CHAUR Biobank, to the regulatory approval of Glybera through his close cooperation with uniQure.

This is the first gene therapy ever to be approved by the European Union. The project, which we hope will lead the way to the approval of other treatments, is proof that genomics has matured to the point of producing therapies for the benefit of society.  

Read more (in French only):


Back to news list